ArticleFrontiers in veterinary science2025
Building capacities in Sub-Saharan African countries for antimicrobial resistance surveillance in the food and agriculture sectors using the FAO ATLASS tool.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Role of Migratory Birds in the Dissemination of Antimicrobial Resistance: A One Health Perspective.Veterinary sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
FAO has developed the 'Assessment Tool for Laboratories and AMR Surveillance Systems" (FAO-ATLASS) to support the national food and agriculture sectors in describing and assessing their AMR surveillance system in a standardized manner. Between 2018 and 2024, 221 laboratories and 24 national AMR surveillance systems were assessed in 27 Sub-Saharan African countries. The assessments assigned Progressive Improvement Pathway (PIP) stages from "1-limited" to "5-sustainable," with stage "3-developed" considered sufficient for reliable AMR data production. The compilation of assessments enabled identification of common gaps that guided FAO interventions to efficiently support capacity building for AMR surveillance in Africa. The impact of the evaluations and follow-up interventions was investigated through a post-ATLASS survey involving 15 of the 27 countries assessed and 112 of the 221 laboratories. The assessments showed that 21 (9.5%) and 6 (2.7%) laboratories were at PIP stages 3 and 4, respectively, while other laboratories (86.5%) are at PIP stage 1 and 2. Two (8.3%) AMR surveillance systems were at PIP stage 3, and others (92.6%) were at PIP stage 1 or 2. Quality assurance was the most critical gap for laboratories; the access to reference strains, reagents, and participation to proficiency testing (PT) scheme were among the major common concerns. For surveillance systems, the data production (laboratory network and data collection/analysis) were the main areas to improve. The post-ATLASS survey carried out in 2024 indicated that over 90% of the countries and 50% of laboratories received support from FAO and partners mainly for training, provision of reagents and equipment (60%), enrolment in PT program (73%), development of AMR surveillance strategy and SOPs on AMR detection (53%). Ten laboratories moved from PIP stage 2 to 3, eight from stage 1 to 2, and two from stage 2 to 4. For about 60% of the laboratories, the respondents reported that the management showed better commitment in supporting AMR activities. Implementation of AMR surveillance is now effective in 80% of the countries surveyed (initial of 33%). The results of this analysis indicate that AMR surveillance systems are progressively improving in African countries; however, sustained efforts are necessary to ensure the production of reliable data in the majority of countries and to inform evidence-based interventions against AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.